Radiation Therapy News and Research

RSS
Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
Novel drug combinations improve progression-free survival for patients with advanced NSCLC

Novel drug combinations improve progression-free survival for patients with advanced NSCLC

Tumor-related risk factors affect conversion of active surveillance to treatment for prostate cancer

Tumor-related risk factors affect conversion of active surveillance to treatment for prostate cancer

First-in-human trial proves feasibility of Temporally Feathered Radiation Therapy

First-in-human trial proves feasibility of Temporally Feathered Radiation Therapy

Targeting and inhibiting a protein could provide more effective treatment for brain cancer

Targeting and inhibiting a protein could provide more effective treatment for brain cancer

Combination of metformin and chemoradiation does not add survival benefit in patients with LA-NSCLC

Combination of metformin and chemoradiation does not add survival benefit in patients with LA-NSCLC

Intestinal microorganisms help regulate anti-tumor immune responses to radiation therapy, study finds

Intestinal microorganisms help regulate anti-tumor immune responses to radiation therapy, study finds

Waterloo experts are developing new cancer treatments with high-intensity focused ultrasound

Waterloo experts are developing new cancer treatments with high-intensity focused ultrasound

Study provides new data on discontinuation of active surveillance by low-risk prostate cancer patients

Study provides new data on discontinuation of active surveillance by low-risk prostate cancer patients

Study in dogs may lead to better understanding of how gliomas affect the immune system

Study in dogs may lead to better understanding of how gliomas affect the immune system

Study identifies Foxo1 gene as a potential treatment target for hereditary lymphedema

Study identifies Foxo1 gene as a potential treatment target for hereditary lymphedema

Covid renews interest in radiation, but docs caution against pilgrimages to radon-filled mines

Covid renews interest in radiation, but docs caution against pilgrimages to radon-filled mines

Investigational Oncomagnetic Device shrinks end-stage recurrent glioblastoma

Investigational Oncomagnetic Device shrinks end-stage recurrent glioblastoma

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer

Research reveals clues to how a molecule improves appearance of surgery scars

Research reveals clues to how a molecule improves appearance of surgery scars

Antihypertension drug may benefit patients with neurofibromatosis type 2

Antihypertension drug may benefit patients with neurofibromatosis type 2

Quantum physics helps trigger cancer cell death

Quantum physics helps trigger cancer cell death

WVU researcher-led effort ensures accuracy of data that dictates cancer patient's radiation therapy

WVU researcher-led effort ensures accuracy of data that dictates cancer patient's radiation therapy

Researchers seek to find a cure for the deadliest solid tumor in children

Researchers seek to find a cure for the deadliest solid tumor in children

Review: Endovascular therapy is the safest, most effective treatment for superior vena cava syndrome

Review: Endovascular therapy is the safest, most effective treatment for superior vena cava syndrome

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

New antibody conjugate delivers drugs to bone tumors and inhibits metastasis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.